U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
LADIRATUZUMAB
INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN ZINC TRANSPORTER LIV-1) (HUMAN-MUS MUSCULUS MONOCLONAL HLIV22 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HLIV22 .KAPPA.-CHAIN, DIMER
Preferred Name English
ladiratuzumab [INN]
Common Name English
Code System Code Type Description
SMS_ID
300000025304
Created by admin on Tue Apr 01 21:08:09 GMT 2025 , Edited by admin on Tue Apr 01 21:08:09 GMT 2025
PRIMARY
INN
10630
Created by admin on Tue Apr 01 21:08:09 GMT 2025 , Edited by admin on Tue Apr 01 21:08:09 GMT 2025
PRIMARY
NCI_THESAURUS
C170090
Created by admin on Tue Apr 01 21:08:09 GMT 2025 , Edited by admin on Tue Apr 01 21:08:09 GMT 2025
PRIMARY
FDA UNII
L0BJ40AQ0J
Created by admin on Tue Apr 01 21:08:09 GMT 2025 , Edited by admin on Tue Apr 01 21:08:09 GMT 2025
PRIMARY
CAS
1629760-28-6
Created by admin on Tue Apr 01 21:08:09 GMT 2025 , Edited by admin on Tue Apr 01 21:08:09 GMT 2025
PRIMARY
ACTIVE MOIETY
LADIRATUZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966